CIK 0001875558 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Nuvectis Pharma, Inc.
Sign in to watch- Ticker
- NVCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862405608
- Phone
- 360-837-7232
- Business address
- 1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Shemesh Shay Chief Dev. & Ops. Officer | Grant or award | +150,000 | 1,643,068 | ||
| 2025-01-02 | Poradosu Enrique Chief Science & Business Off | Grant or award | +150,000 | 1,656,319 | ||
| 2025-01-02 | Carson Michael J. Vice President, Finance | Grant or award | +51,000 | 138,918 | ||
| 2025-01-02 | BENTSUR RON Chairman & CEO | Grant or award | +250,000 | 3,520,924 | ||
| 2024-12-24 | BENTSUR RON Chairman & CEO | Purchase | +4,500 | $4.65 | $21K | 3,270,924 |
| 2024-12-13 | Mosseri Marlio Charles 10% owner | Purchase | +17,000 | $4.70 | $80K | 2,644,121 |
| 2024-12-13 | Mosseri Marlio Charles 10% owner | Purchase | +17,000 | $4.70 | $80K | 2,612,000 |
| 2024-12-12 | Mosseri Marlio Charles 10% owner | Purchase | +32,121 | $4.64 | $149K | 2,627,121 |
| 2024-11-19 | Poradosu Enrique Chief Science & Business Off | Purchase | +2,000 | $4.99 | $10K | 1,506,319 |
| 2024-11-15 | BENTSUR RON Chairman & CEO | Purchase | +20,000 | $4.92 | $98K | 3,266,424 |
| 2024-11-07 | Carson Michael J. Vice President, Finance | Sale | −2,755 | $8.16 | $22K | 87,918 |
| 2024-06-13 | Kaplan Matthew L. Director | Grant or award | +30,000 | 83,760 | ||
| 2024-06-13 | Hoberman Kenneth Director | Grant or award | +30,000 | 103,140 | ||
| 2024-06-13 | Oliviero James F III Director | Grant or award | +30,000 | 57,828 | ||
| 2024-05-14 | BENTSUR RON Chairman & CEO | Purchase | +1,940 | $6.74 | $13K | 3,246,424 |
| 2024-05-10 | BENTSUR RON Chairman & CEO | Purchase | +2,000 | $6.40 | $13K | 3,244,484 |
| 2024-05-10 | Poradosu Enrique Chief Science & Business Off | Purchase | +500 | $6.29 | $3K | 1,504,319 |
| 2024-05-10 | Shemesh Shay Chief Dev. & Ops. Officer | Purchase | +1,113 | $6.32 | $7K | 1,493,068 |
| 2024-03-18 | BENTSUR RON Chairman & CEO | Purchase | +5,000 | $10.29 | $51K | 3,242,484 |
| 2024-01-04 | Carson Michael J. Vice President, Finance | Grant or award | +34,567 | 90,673 |
Page 3 of 7 · 136 trades